Tosoh Acquires US Venture for Continuous Biopharma Production Oct. 29, 2021 Filed Under: Pharma Tagged With: acquisitions, biopharmaceuticals, continuous production, investments, M&A, pharmaceutical, Semba Biosciences, tosohTosoh Corp. (TYO:4042) has acquired Semba Biosciences, Inc., a U.S.-based chromatography equipment company. The Japanese firm aims through this deal…... Please subscribe to read the full story. Subscribe Free Trial Related Articles:Tosoh Moves Quickly on Turning Development Themes Into…Toray Enables Massive Biopharma Savings With New Continuous…Tosoh Focuses on PPS for 5G ApplicationsToray Develops All-Carbon CO2 Separation Membrane With…Tosoh Considers Setting up Electrolysis Facilities OverseasTosoh Targets Growth Markets With High-Value-Added PE